Madrigal Pharmaceuticals inc. buy melinda
Start price
06.06.12
/
50%
€156.52
Target price
06.12.12
€175.00
Performance (%)
27.93%
End price
06.12.12
€200.24
Summary
This prediction ended on 06.12.12 with a price of €200.24. The prediction had a final performance of 27.93%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Madrigal Pharmaceuticals inc. | -1.538% | -1.538% | 35.840% | 224.638% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by melinda for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Lunge
Synta pharma.corp der Titel bis die Ergebnisse der Prüfung seiner Medikament hat bei Patienten mit Lungenkrebs Potenzial
(Laufzeit überschritten)
Stopped prediction by melinda for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€96.54
23.11.20
23.11.20
€108.00
23.11.21
23.11.21
-25.42%
24.11.21
24.11.21
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€124.73
26.02.18
26.02.18
€135.30
31.05.18
31.05.18
56.77%
31.05.18
31.05.18
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€73.53
06.12.17
06.12.17
€90.20
29.12.17
29.12.17
14.44%
29.12.17
29.12.17
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€40.66
23.10.17
23.10.17
€49.61
01.11.17
01.11.17
10.91%
01.11.17
01.11.17
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€170.38
26.09.13
26.09.13
€210.00
26.03.14
26.03.14
-34.33%
26.03.14
26.03.14